Table 1.
Characteristic | Full Study Cohort (N = 2,677) |
---|---|
Gestational age, wk, mean (SD) | 25.2 (1.3) |
<27 wk, n (%) | 2,380 (89) |
27 wk to 31 wk and 6 d, n (%) | 297 (11) |
Birth weight, g, mean (SD) | 765 (168) |
Sex, male, n (%) | 1,356 (51) |
Small for gestational age, n (%)* | 219 (8) |
Race, n (%) | |
Black | 1,225 (46) |
White | 1,312 (49) |
Other | 140 (5) |
Ethnicity, n (%) | |
Hispanic | 322 (12) |
Non-Hispanic | 2,355 (88) |
Corrected age at follow-up, mo, mean (SD) | 23.3 (3.0) |
Follow-up at 18–22 mo corrected age, n (%)† | 719 (28) |
Follow-up at 22–26 mo corrected age, n (%)† | 1,849 (72) |
Antenatal corticosteroids, n (%) | 2,397 (90) |
Antenatal magnesium, n (%) | 2,077 (78) |
Maternal marital status, married, n (%) | 1,126 (42) |
Insurance type, n (%) | |
Medicaid | 1,528 (57) |
Private | 1,012 (38) |
Self-pay/uninsured | 101 (4) |
Other | 36 (1) |
Maternal level of education less than high school, n (%) | 499 (19) |
Outcome | |
Late death or serious respiratory morbidity, n (%) | 683 (26) |
Late death or moderate to severe NDI, n (%) | 1,305 (49) |
Definition of abbreviation: NDI = neurodevelopmental impairment.
Defined as a birth weight below the 10th percentile for gestational age and sex (25).
Calculated for the 2,568 infants who survived to follow-up testing.